Globus Medical, Inc.
GMED
$76.64
-$0.57-0.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 216.18% | 422.28% | 363.08% | 776.83% | 178.51% |
| Total Depreciation and Amortization | 6.43% | 9.09% | 6.66% | 18.81% | 44.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.51% | -97.73% | -85.27% | -86.59% | 82.78% |
| Change in Net Operating Assets | -131.05% | 31.53% | 89.41% | 107.30% | 67.27% |
| Cash from Operations | 20.60% | 44.72% | 72.35% | 155.60% | 166.13% |
| Capital Expenditure | -36.78% | -42.67% | -11.88% | -40.63% | -35.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -2,478.16% | -1,360.43% | -1,360.43% | 17.13% | 96.74% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -280.49% | 256.35% | -88.27% | -81.07% | -79.00% |
| Cash from Investing | -34,983.89% | -101.65% | -239.81% | -256.91% | -99.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -11.63% | -18.73% | 128.18% | 394.35% | 979.80% |
| Repurchase of Common Stock | 41.99% | -227.90% | 20.95% | 32.65% | 39.48% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.91% | 65.87% | 49.26% | 48.42% | 47.99% |
| Cash from Financing | 95.33% | -2,352.20% | -94.84% | -69.46% | -56.18% |
| Foreign Exchange rate Adjustments | 122.53% | 8,701.96% | 237.63% | 691.99% | 742.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.01% | -181.44% | -173.15% | -274.06% | -21.39% |